Xeno Biosciences logo

Xeno Biosciences jobs and careers

About Xeno Biosciences

Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.It wasfounded in 2015 and is headquartered in Somerville, Massachusetts.

Employees
1 to 10

Leadership

The top of Xeno Biosciences's org chart, with how many people report into each leader.

DD

David Beno, Ph.D.

Advisor